Riley Whalen is a PhD candidate in biomedical science at Oregon Health & Science University completing her thesis training in Dr. Tanaya Shree's laboratory. Riley studies mechanisms of resistance to bispecific antibody therapy in B cell lymphoma. Using patient samples and in vitro co-culture models, her research focuses on how tumor-derived signals can enhance bispecific antibody activity and the effects of engaging diverse T cell subsets. Riley's goal is to increase our understanding of cancer immunology in order to improve immunotherapy strategies and patient outcomes.
Riley Whalen is a PhD candidate in biomedical science at Oregon Health & Science University completing her thesis training in Dr. Tanaya Shree's laboratory. Riley studies mechanisms of resistance to bispecific antibody therapy in B cell lymphoma. Using patient samples and in vitro co-culture models, her research focuses on how tumor-derived signals can enhance bispecific antibody activity and the effects of engaging diverse T cell subsets. Riley's goal is to increase our understanding of cancer immunology in order to improve immunotherapy strategies and patient outcomes.